[1] Bruce H.The Eric declaration the critical role of commun-ication in drug safety[J]. Drug Safety, 2006, 29(1): 91-93. [2] Guo XX, Wu ZA, Zhang CX.Communications in drug risk Management[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2008, 5(1): 12-13, 32. [3] Ning YY, Yang Y.Implication of American drug risk management for China[J]. Chinese Journal of New Drugs(中国新药杂志), 2010, 19(23): 2120-2123. [4] Zhang J, Zhang TF.Research on risk communication in the U.S.: academic evolution, core propositions and key factors[J]. Chinese Journal of Journalism & Communication(国际新闻界), 2009(9): 95-101. [5] Dominic W, Hortense B, Ragnar L, et al.Pharma-ceutical benefit-risk communication tools: a review of the Literature[J]. Drug Saf, 2017, 40(1): 15-36. [6] Su J, Zhang J.From crisis transmission to risk communication-the transformation of the transmission of public health emergencies[J]. News and Writing(新闻与写作), 2020(4): 5-13. [7] Regina EL, Andrea HM.Risk Communication: A Handbook for Communicating Environmental, Safety and Health Risks (Fifth Edition)(风险沟通:环境、安全和健康风险沟通指南,第五版)[M]. Beijing: Communication University of China Press, 2016. [8] ICH Work Office. Quality risk management Q9 [EB/OL]. (2005-11-09) [2020-06-09]. http://www.cde.org.cn/ichWeb/serarch/serarchTitle. [9] Li S, Yang Y.Drug risk communication method of America and Canada and its implication in China[J]. Chinese Journal of New Drugs(中国新药杂志), 2012, 21(18): 2104-2108. [10] FDA. NDA 21-410/S-005 and S-006 NDA 21-071/S-009[EB/OL]. (2004-05-19) [2020-11-09]. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21071slr009,21410slr005,006ltr.pdf. [11] Tadashi T, Shunsuke O.Spontaneous reporting on adverse events by consumers in the United States: an analysis of the food and drug administration adverse event reporting system database[J]. Drugs - Real World Outcomes, 2018(5): 117-128. [12] FDA. Guidance drug safety information-FDA’s communication to the public [EB/OL]. (2012-03) [2020-04-05]. https://www.fda.gov/media/83097/download. [13] George RB, Tu YR, Sun PH, et al.U.S. FDA drug safety information communication platform and drug quality reporting system[J]. Chinese Journal of New Drugs(中国新药杂志), 2014, 23(13): 1514-1520. [14] Cao F, Sun J, Ni XX, et al.Drug safety information of FDA and the inspiration to our country[J]. Pharmaceutical and Clinical Research(药学与临床研究), 2012, 20(2): 166-168. [15] Gao X, Zhang SZ, Yang GL, et al.Overview on research status of risk communication[J]. Journal of Safety Science and Technology(中国安全生产科学技术), 2011, 7(5): 148-152. |